DiaMedica Therapeutics announced the appointment of Lorianne Masuoka as chief medical officer. Masuoka is a board-certified neurologist with more than 25 years of experience and a successful track record of managing clinical programs from early stage to drug approvals and strategic alliances.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
